MENU
VRNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Verona Pharma (VRNA) Ownership - Who owns Verona Pharma?

Profile

Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.41B
P/E Ratio
N/A
Total Cash
336.04M
Projected Growth
N/A
Total Debt
122.31M
Revenue
5.62M
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash/Share
4.11
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price

Fundamentals

VRNA
Capitalization
3.41B
P/E Ratio
N/A
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash
336M
Total Cash/Share
4.11
Total Debt
122M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
5.62M
ROE
N/A
Book Value
130M
P/B Ratio
26.11
Cash Flow
N/A
Earnings
-2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
42.8M
Current Ratio
13.03
Current Revenue Per Employee
71189.88
Dividends Per Share - Security
N/A
EBITDA
-136.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.34
Revenue To Assets
-45.60
Shares Held By Institutions
1.6B
Shares Outstanding - Current
81.8M
Total Liabilities
251M
Total Volume MTD
N/A
Value
-1
Gain YTD
114.688
View a ticker or compare two or three
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com